Haemonetics Q3 2026 Earnings Preview
Source: SeekingAlpha
2026-02-04 09:36:45 ET
More on Haemonetics
- Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Haemonetics: Re-Rating Complete, Time To Cash In
- Haemonetics Is Still Undervalued, Even After The Rally
- Haemonetics acquires Vivasure Medical
- Haemonetics downgraded at Needham on vascular closure device competition
Read the full article on Seeking Alpha
For further details see:
Haemonetics Q3 2026 Earnings Preview
Haemonetics Corporation
NASDAQ: HAE
HAE Trading
-2.43% G/L:
$60.75 Last:
311,256 Volume:
$62.37 Open:
HAE Latest News
February 23, 2026 04:15:00 pm
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
February 20, 2026 04:05:00 pm
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
HAE Stock Data
$2,748,315,639
45,616,277
0.08%
124
N/A
Medical Equipment & Supplies
Healthcare
US
Boston
